308 participants
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-02
- Start Date:
- 2021-01-12
- Completion:
- 2024-04-15
Conditions
- Squamous Cell Carcinoma of the Anal Canal
Interventions
- DRUG